Clinical Trials Browser

OTHER_GOV × Carcinoma × Sorafenib × Clear all

NCT01214343 2011-06-15

Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

Phase 3 Unknown

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms